Standard physicals are, well, pretty standard. During a visit geared more toward detecting disease than preventing it, your doctor makes you cough and checks your numbers. If there’s an abnormality -- your blood pressure has spiked or your liver enzymes are elevated -- it’s your schedule that suffers as you’re shuttled between specialists.
Roche Holding AG’s experimental leukemia drug shrank tumors in more patients when added to chemotherapy, according to study results that may aid the company in expanding its line of blood-cancer treatments.
Adcock Ingram Holdings Ltd., South Africa’s largest supplier of hospital products, may gain a further 12 percent from yesterday’s 30-month high after it got takeover offers, according to JPMorgan Chase & Co.
Witnesses for Intuitive Surgical Inc. testified that heart disease, not a failed robotic procedure, killed a patient whose widow is suing the company over claims that overly aggressive marketing caused surgical errors.
Aveo Pharmaceuticals Inc. failed to win the backing of U.S. regulatory advisers for its lead product candidate, a kidney cancer drug, after the panelists questioned whether it was as effective as existing treatments.